The Beauty Health Company Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
The Beauty Health Company (SKIN) PT Raised to $35 at DA Davidson
February 23, 2022 11:59 AM ESTDA Davidson analyst Linda Bolton Weiser raised the price target on The Beauty Health Company (NASDAQ: SKIN) to $35.00 (from $32.00) while maintaining a Buy rating following results.
The analyst commented, "Although SKIN had pre-announced on January 10th that 4Q21 would be in line, it... More
The Beauty Health Company (SKIN) Misses Q4 EPS by 10c, Revenue Beats, Offers Guidance
February 22, 2022 4:16 PM ESTThe Beauty Health Company (NASDAQ: SKIN) reported Q4 EPS of ($0.12), $0.10 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $77.9 million versus the consensus estimate of $71.1 million.
GUIDANCE:
The Beauty Health Company sees 2022 revenue of $320-330 million, versus... More
